2006
DOI: 10.1007/s00134-006-0205-7
|View full text |Cite
|
Sign up to set email alerts
|

Is the measurement of monocytes HLA-DR expression useful in patients with sepsis?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
18
0
1

Year Published

2008
2008
2015
2015

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 24 publications
(20 citation statements)
references
References 20 publications
1
18
0
1
Order By: Relevance
“…In adults, physiological immunodepression is protective against overwhelming inflammation, whereas excessive or prolonged immunodepression associates with increased morbidity and death [23,24]. In VLBW infants, reduced monocyte HLA-DR expression associated with risk for infections, respiratory distress syndrome, and bronchoplastic pulmonary disease, along with a clear association with gestational age [14,15], supporting the general notion that immunodepression per se may associate with adverse outcome [25].…”
Section: Discussionmentioning
confidence: 56%
“…In adults, physiological immunodepression is protective against overwhelming inflammation, whereas excessive or prolonged immunodepression associates with increased morbidity and death [23,24]. In VLBW infants, reduced monocyte HLA-DR expression associated with risk for infections, respiratory distress syndrome, and bronchoplastic pulmonary disease, along with a clear association with gestational age [14,15], supporting the general notion that immunodepression per se may associate with adverse outcome [25].…”
Section: Discussionmentioning
confidence: 56%
“…For example, mHLA-DR expression has been shown to be positively and negatively regulated by cytokines such as IFN-γ and IL-10, as well as by corticoids and catecholamines (83)(84)(85)(86). There is general consensus that diminished mHLA-DR expression may be a reliable marker for immunosuppression in critically ill patients (47,87,88).…”
Section: Antigen-presenting Cells: Monocytesmentioning
confidence: 99%
“…Therefore, multicenter clinical trials need to be designed with appropriate numbers of patients prospectively selected on the basis of well-defined criteria and ultimately classified on the basis of well-defined outcomes (87). A prerequisite for all centers performing mHLA-DR measurements should also be the standardization of the different protocols.…”
Section: Mhla-dr Expression and Clinical Studymentioning
confidence: 99%
“…Multiple studies have demonstrated clearly that following either trauma or sepsis, monocytes have diminished capacity for both these responses. Specifically, they secrete fewer cytokines when stimulated and down-regulate expression of HLA receptors 2430. Monocytes from septic patients who had decreased mHLA-DR produced low amounts of TNF-α and IL-1 in response to bacterial challenges 31.…”
Section: Antigen-presenting Cellsmentioning
confidence: 99%
“…A larger number of studies, however, have focused on monocytes and their apparent down-regulation of HLA receptors as a biomarker 24,25,27,28,60–65. In 1995, Asadulla and colleagues24 studied 57 neurosurgical patients and found that HLA-DR expression was lower in 14 patients who developed infection, compared with patients who had an uncomplicated postoperative course ( P < .0001).…”
Section: Clinical Significance Of Understanding Compensatoryanti-inflmentioning
confidence: 99%